LDH: Northshore COVID-19 testing, vaccination sites to close or operate on limited hours due to weather
The five Northshore parish health units will offer testing and/or vaccinations during limited hours, 12 to 3 p.m., on Friday.
An official website of the State of Louisiana.
The five Northshore parish health units will offer testing and/or vaccinations during limited hours, 12 to 3 p.m., on Friday.
The Louisiana Department of Health's (LDH) community-based COVID-19 vaccine and testing sites in Region 2 (Baton Rouge area) will have a delayed opening on Friday, Jan. 21, due to the forecasted weather on that day.
The Louisiana Department of Health's (LDH) community-based COVID-19 testing sites in Region 4 (Acadiana) will have a delayed opening on Friday, Jan. 21 due to the forecasted weather, and the Ville Platte Civic Center testing site will be closed on that day.
Sites affected are Lutcher Senior Center and Houma Municipal Center.
Vaccine sites will operate during regular hours on Thursday and will close on Friday. Parish health units will continue to operate as normal on Friday.
The Louisiana Department of Health reported 29,125 new cases Tuesday since January 14, bringing the total number of confirmed cases to 1,025,748.
Continues the provisions of the April 8, 2020, October 19, 2020, and December 10, 2020 Emergency Rules which amend Title 50 of the Louisiana Administrative Code throughout the duration of the COVID-19 public health emergency declaration.
The Centers for Disease Control and Prevention (CDC) has updated its recommendations for the Moderna booster, shortening the 6 month interval between completing the Moderna COVID-19 vaccine series and receiving a booster dose to 5 months.
LDH has reviewed the latest CDC recommendations and alerted all vaccine providers in the state that this guidance is effective immediately.
The Louisiana Department of Health (LDH) estimates the proportion of Omicron cases in our state has increased from 88.5% to 90.2% for the week ending January 1.
Do not visit an emergency room simply to obtain a test if you have mild or no symptoms. Emergency rooms are for the seriously ill or people needing immediate medical attention.
The U.S. Food and Drug Administration recently issued an Emergency Use Authorization for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets) - the first oral treatment for COVID-19.